Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Retatrutide is a once-weekly injectable triple agonist (GLP-1, GIP, and glucagon receptor) developed by Eli Lilly for obesity and type 2 diabetes
Stable Quality: Scalable batch production ensures high consistency and minimal lot-to-lot variation
Spots are uneven, irregular, or grow fast
Before Zepbound, she estimates she spent two to three hours a day thinking about food (e.g., what to order, whether she'd been disciplined enough to justify what she was craving)
US$ 25.40
US$ 27.54
US$ 24.73
US$ 26.60
US$ 25.01
US$ 20.72
US$ 26.16
US$ 29.56
US$ 21.48
US$ 24.95
US$ 27.94
US$ 26.67
US$ 29.83
US$ 23.29
